IP Verse

Dorr patent opposition analysis

The comprehensive analysis of Dorr opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Dorr

Stay updated with the latest patent oppositions filed by Dorr

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4096717
Treatment Of CancerINNATE PHARMASep 11, 2025STRAWMAN
EP3313373
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DORRIES
EP3824879
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DORRIES
EP3684786
Mutated Glycoprotein Of Vesicular Stomatitis VirusUNIVERSITE PARIS SUDMay 14, 2025DORRIES
EP2818163
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTFeb 26, 2025RATIOPHARM
EP4069368
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 15, 2025DORRIES
EP3110848
Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSNov 13, 2024DORRIES
EP3515465
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 7, 2024DORRIES
EP3167888
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALSOct 28, 2024AMGEN TECHNOLOGY IRELAND UNLIMITED
EP3791896
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerASTELLAS PHARMAOct 10, 2024DR H ULRICH DORRIES

Top clients of Dorr

Top companies who are the clients of Dorr

CompanyTotal
DR H ULRICH DORRIES44
DORRIES13
PFIZER10
JOHNS MANVILLE8
AMGEN6
ZOETIS SERVICES6
AMGEN TECHNOLOGY IRELAND UNLIMITED4
FRIEDRICH4
RATIOPHARM2
CEVA ANIMAL HEALTH2